WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ: RGEN) announced today that Ms. Karen A. Dawes has been elected to serve as co-chairperson of the Board of Directors along with Mr. Alexander Rich, M.D. Ms. Dawes has served as a Director of Repligen since September of 2005 and has extensive experience in the pharmaceutical and biotechnology industry in the development of worldwide marketing and sales teams and commercialization strategies.
